Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Shaghayegh Hosseinkhani"'
Autor:
Alireza Azarboo, Shaghayegh Hosseinkhani, Amirhossein Ghaseminejad-Raeini, Hossein Aazami, Sayed Mohammad Mohammadi, Saba Zeidi, Farideh Razi, Fatemeh Bandarian
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0295607 (2024)
BackgroundPrevious research has suggested that the ELMO1 gene may play a role in the development of diabetic kidney disease. Diabetic kidney disease (DKD) is a serious complication of diabetes and the leading cause of chronic kidney disease and end-s
Externí odkaz:
https://doaj.org/article/abd3d9bdb3d24dbcad9ebfd3bb067585
Autor:
Shaghayegh Hosseinkhani, Pooneh Salari, Fatemeh Bandarian, Mojgan Asadi, Shapour Shirani, Niloufar Najjar, Hojat Dehghanbanadaki, Parvin Pasalar, Farideh Razi
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Diabetes mellitus (DM) and its cardiovascular disease (CVD) complication are among the most frequent causes of death worldwide. However, the metabolites linking up diabetes and CVD are less understood. In this study, we aimed to e
Externí odkaz:
https://doaj.org/article/c66ac553a93f44e29d55e3cb6f69427f
Autor:
Hojat Dehghanbanadaki, Salimeh Dodangeh, Peyvand Parhizkar Roudsari, Shaghayegh Hosseinkhani, Pouria Khashayar, Mohammad Noorchenarboo, Negar Rezaei, Arezou Dilmaghani-Marand, Moein Yoosefi, Babak Arjmand, Kazem Khalagi, Niloufar Najjar, Ardeshir Kakaei, Fatemeh Bandarian, Hamid Aghaei Meybodi, Bagher Larijani, Farideh Razi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundThe intermediate metabolites associated with the development of atherosclerotic cardiovascular disease (ASCVD) remain largely unknown. Thus, we conducted a large panel of metabolomics profiling to identify the new candidate metabolites that
Externí odkaz:
https://doaj.org/article/b271b07c63224611a0bba4f28f5788df
Autor:
Shaghayegh Hosseinkhani, Babak Arjmand, Arezou Dilmaghani-Marand, Sahar Mohammadi Fateh, Hojat Dehghanbanadaki, Niloufar Najjar, Sepideh Alavi-Moghadam, Robabeh Ghodssi-Ghassemabadi, Ensieh Nasli-Esfahani, Farshad Farzadfar, Bagher Larijani, Farideh Razi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Diabetes is a common chronic disease affecting millions of people worldwide. It underlies various complications and imposes many costs on individuals and society. Discovering early diagnostic biomarkers takes excellent insight into preventiv
Externí odkaz:
https://doaj.org/article/38ba16dcc3e54cce92dfc37adf459283
Autor:
Hananeh Taghizadeh, Solaleh Emamgholipour, Shaghayegh Hosseinkhani, Babak Arjmand, Negar Rezaei, Arezou Dilmaghani-Marand, Erfan Ghasemi, Nekoo Panahi, Hojat Dehghanbanadaki, Robabeh Ghodssi-Ghassemabadi, Niloufar Najjar, Mojgan Asadi, Mohsen khoshniat, Bagher Larijani, Farideh Razi
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundEvidence, albeit with conflicting results, has suggested that cardiometabolic risk factors, including obesity, type 2 diabetes (T2D), dyslipidemia, and hypertension, are highly associated with changes in metabolic signature, especially plas
Externí odkaz:
https://doaj.org/article/bb2cb731ea7a40a291fbfa485f292b9d
Autor:
Babak Arjmand, Hojat Dehghanbanadaki, Moein Yoosefi, Negar Rezaei, Sahar Mohammadi Fateh, Robabeh Ghodssi-Ghassemabadi, Niloufar Najjar, Shaghayegh Hosseinkhani, Akram Tayanloo-Beik, Hossein Adibi, Farshad Farzadfar, Bagher Larijani, Farideh Razi
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279835 (2023)
BackgroundIdentification of metabolomics profile in subjects with different blood pressure, including normal blood pressure, elevated blood pressure, stage 1 hypertension, and stage 2 hypertension, would be a promising strategy to understand the path
Externí odkaz:
https://doaj.org/article/2d98a56912b94c848dee52693e248a4d
Autor:
Shaghayegh Hosseinkhani, Hojat Dehghanbanadaki, Hossein Aazami, Parvin Pasalar, Mojgan Asadi, Farideh Razi
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Gestational diabetes mellitus (GDM) is associated with increased risks of disease for mother and child during pregnancy and after that. Early diagnosis of GDM would promote both maternal and fetal health. Metabolomics can simplify
Externí odkaz:
https://doaj.org/article/6d101d1b61f24383a9baa6c5adb1f5e3
Autor:
Shaghayegh Hosseinkhani, Solaleh Emamgholipour, Pooneh Salari, Kazem Khalagi, Shapour Shirani, Niloufar Najjar, Bagher Larijani, Parvin Pasalar, Farideh Razi
Publikováno v:
Menopause. 29:1062-1070
Postmenopausal women are at increased risk of developing coronary artery disease (CAD). Metabolomic approaches aim at discovering more helpful biomarkers of CAD to reduce the disease burden in the future. Here, we intend to find potential blood bioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ca39e395ae02e3bd4462b1fc394f31
https://doi.org/10.1097/gme.0000000000002016
https://doi.org/10.1097/gme.0000000000002016
Autor:
Ali Etemadi, Houra Mobaleghaleslam, Maryam Mirabolghasemi, Mehdi Ahmadi, Hojat Dehghanbanadaki, Shaghayegh Hosseinkhani, Fatemeh Bandarian, Niloufar Najjar, Arezou Dilmaghani-Marand, Nekoo Panahi, Babak Negahdari, Mohammadali Mazloomi, Mohammad Hossein Karimi-jafari, Farideh Razi, Bagher Larijani
Background: The Discovery of underlying intermediates associated with the development of dyslipidemia results in a better understanding of pathophysiology of dyslipidemia and their modification will be a promising preventive and therapeutic strate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aefe4e41393e433289e4d6677326ce7a
https://doi.org/10.21203/rs.3.rs-2400804/v1
https://doi.org/10.21203/rs.3.rs-2400804/v1
Autor:
Solaleh Emamgholipour, Ziba Majidi, Shaghayegh Hosseinkhani, Javad Hashemi, Fatemeh Ghorbani, Mehdi Koushki, Sara Tutunchi, Nasrin Amiri-Dashatan
Publikováno v:
Journal of Investigative Medicine. 69:697-703
Patients with type 2 diabetes have high levels of malondialdehyde (MDA), and clinical data suggest a reducing effect of rosiglitazone (RSG) on the level of MDA in these patients. However, the results of available studies on the level of MDA in RSG-tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376d74d3dfd0cec1af28521e19778a82
https://doi.org/10.1136/jim-2020-001588
https://doi.org/10.1136/jim-2020-001588